| Not Yet Recruiting | Dose Ranging Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Rectal Foam in Pediatr Ulcerative Colitis | Phase 4 | 2027-06-01 |
| Not Yet Recruiting | Efficacy and Safety of Bupropion Hydrobromide in Adolescents and Children With Major Depressive Disorder Major Depressive Disorder | Phase 4 | 2026-06-01 |
| Not Yet Recruiting | Study to Assess Safety, Pharmacokinetics, and Treatment Effect of Cabtreo Acne Vulgaris | Phase 4 | 2026-04-01 |
| Recruiting | Rifaximin 200 mg Plus Oral Rehydration vs Oral Rehydration Alone in Children With Acute Diarrhea Diarrhea, Gastroenteritis, Bacterial Infection | Phase 4 | 2026-02-11 |
| Recruiting | Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis ( Hepatitis | Phase 3 | 2026-01-29 |
| Recruiting | A Prospective Controlled Study to Evaluate the Safety and Effectiveness of Thermage® FLX Radiofrequency Treatm Wrinkle, Lax Skin, Lines Skin | N/A | 2025-10-31 |
| Active Not Recruiting | A Phase 4 Clinical Study to Investigate the Effectiveness and Safety of Skin Resurfacing Skin Resurfacing | N/A | 2025-10-17 |
| Active Not Recruiting | Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Triple Combination Gel in Canadian Patients With Acne V Acne Vulgaris | — | 2025-10-02 |
| Recruiting | Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatr Ulcerative Colitis | Phase 4 | 2023-09-29 |
| Active Not Recruiting | Evaluation of Rifaximin SSD for Delaying Encephalopathy Decompensation in Patients With Cirrhosis Hepatic Encephalopathy | Phase 3 | 2022-08-03 |
| Active Not Recruiting | Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cir Hepatic Encephalopathy | Phase 3 | 2022-04-07 |
| Completed | Pharmacokinetics and Pharmacodynamics of Rifaximin Novel Formulations in Patients With Sickle Cell Disease Sickle Cell Disease | Phase 2 | 2022-03-22 |
| Completed | Safety and Effectiveness of the CLEAR + BRILLIANT TOUCH(R) Diode Laser 1440-nm and 1927-nm Combination Wavelen Photoaging | N/A | 2021-10-27 |
| Active Not Recruiting | Canadian Real World Evidence Study of Brodalumab in Plaque Psoriasis to Understand the Impact on Quality of Li Psoriasis | — | 2021-10-22 |
| Completed | Study Evaluating Efficacy and Safety of Amiselimod (MT-1303) in Mild to Moderate Ulcerative Colitis Ulcerative Colitis | Phase 2 | 2021-09-29 |
| Completed | Study to Compare the Safety and Efficacy of IDP-126 Gel to Epiduo® Forte Gel and Vehicle Gel Acne Vulgaris | Phase 2 | 2021-06-11 |
| Withdrawn | Study to Evaluate the Safety and Efficacy of VIRAZOLE® in Hospitalized Adult Participants With Respiratory Dis COVID19 | Phase 1 | 2021-05-01 |
| Completed | A Safety and Pharmacokinetics Study of IDP-118 Lotion in Pediatric Participants With Plaque Psoriasis Psoriasis | Phase 4 | 2021-03-24 |
| Completed | Safety, Tolerability, and Pharmacokinetics of Inhaled Virazole Administered Via Air-Jet Nebulizer in Healthy V Healthy | Phase 1 | 2021-03-12 |
| Completed | Study to Evaluate the Safety and Efficacy of VIRAZOLE® in Hospitalized Adult Participants With Respiratory Dis COVID19 | Phase 1 | 2021-02-10 |
| Completed | Randomised, Placebo-controlled Safety and Pharmacokinetics Study of Novel Rifaximin Formulations in Healthy Vo Healthy Volunteers | Phase 1 | 2020-09-24 |
| Withdrawn | An Extension Study of Methylnaltrexone Bromide (MNTX) in Participants With Advanced Pancreatic Cancer Pancreatic Cancer | Phase 3 | 2020-02-03 |
| Completed | Clinical Study Comparing the Efficacy and Safety of IDP-126 Gel in the Treatment of Acne Vulgaris Acne Vulgaris | Phase 3 | 2020-01-27 |
| Active Not Recruiting | An Open-label, Single-dose Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Brodalumab in Pedia Psoriasis | Phase 4 | 2020-01-24 |
| Completed | Clinical Study Comparing the Efficacy and Safety of IDP-126 Gel in the Treatment of Acne Vulgaris Acne Vulgaris | Phase 3 | 2020-01-17 |
| Withdrawn | A Study of Methylnaltrexone Bromide (MNTX) in Participants With Advanced Pancreatic Cancer Pancreatic Cancer | Phase 2 / Phase 3 | 2020-01-06 |
| Recruiting | A Safety and Pharmacokinetics Study of IDP-122 Lotion in Pediatric Participants With Plaque Psoriasis Psoriasis | Phase 4 | 2019-10-22 |
| Completed | A Study to Assess the Efficacy and Safety of Salix Probiotic Blend in Participants With Functional Gastrointes Functional Gastrointestinal Disorders | N/A | 2019-10-11 |
| Completed | A Study of Brodalumab (SILIQ®) in Psoriasis Participants With Inadequate Response to Their Current Biologic Ag Psoriasis | — | 2019-09-30 |
| Terminated | Steady-State Pharmacokinetics of Rifaximin 550 mg Tablets in Healthy and Hepatically Impaired Subjects Severe Hepatic Impairment | Phase 4 | 2019-01-29 |
| Completed | Study Comparing the Safety and Efficacy of IDP-120 Gel and IDP-120 Vehicle Gel in the Treatment of Acne Vulgar Acne Vulgaris | Phase 3 | 2018-12-10 |
| Completed | Study Comparing the Safety and Efficacy of IDP-120 Gel and IDP-120 Vehicle Gel in the Treatment of Acne Vulgar Acne Vulgaris | Phase 3 | 2018-12-05 |
| Completed | Rifaximin Soluble Solid Dispersion (SSD) Tablets Plus Lactulose for the Treatment of Overt Hepatic Encephalopa Overt Hepatic Encephalopathy | Phase 2 | 2018-09-13 |
| Completed | Efficacy and Safety of IDP-124 Lotion for the Treatment of Moderate to Severe Atopic Dermatitis in Pediatric a Atopic Dermatitis | Phase 3 | 2018-08-14 |
| Completed | Open-Label, Randomized Study Evaluating the Absorption and Systemic Pharmacokinetics of Topically Applied IDP- Acne Vulgaris | Phase 1 | 2018-08-08 |
| Completed | Efficacy and Safety of IDP-124 Lotion for the Treatment of Moderate to Severe Atopic Dermatitis in Pediatric a Atopic Dermatitis | Phase 3 | 2018-07-24 |
| Completed | Efficacy and Safety of Plecanatide in Children 6 to <18 Years With Irritable Bowel Syndrome With Constipation Irritable Bowel Syndrome With Constipation | Phase 2 | 2018-06-30 |
| Completed | A Postmarketing Study of Plecanatide in Breast Milk of Lactating Women Treated With TRULANCE® Chronic Idiopathic Constipation | — | 2018-06-21 |
| Completed | A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle Controlled, Parallel-Group, Clinical Study in the Tr Acne Vulgaris | Phase 2 | 2017-10-05 |
| Enrolling By Invitation | LTS of Siliq vs. Other Therapies Treating of Adults With Moderate-to-Severe Psoriasis Psoriasis | — | 2017-07-25 |
| Completed | A Phase 3, Vehicle-controlled Efficacy and Safety Study of IDP-123 Lotion in the Treatment of Acne Vulgaris (3 Acne Vulgaris | Phase 3 | 2017-07-11 |
| Completed | A Phase 3, Vehicle-controlled Efficacy and Safety Study of IDP-123 Lotion in the Treatment of Acne Vulgaris (3 Acne Vulgaris | Phase 3 | 2017-06-29 |
| Completed | Randomized,Study of APRISO 375 mg Versus the Approved APRISO 375 mg Capsules in Healthy Male and Female Subjec Ulcerative Colitis | Phase 1 | 2017-05-15 |
| Completed | An Efficacy and Safety Study of Plecanatide in Adolescents 12 to <18 Years of Age With Chronic Idiopathic Cons Chronic Idiopathic Constipation | Phase 2 | 2017-01-01 |
| Completed | Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis Onychomycosis | Phase 4 | 2016-08-04 |
| Completed | Absorption and Systematic Pharmacokinetics of Topically Applied IDP-120 Gel Acne | Phase 1 | 2016-06-01 |
| Completed | Safety and Efficacy of IDP-122 Lotion When Applied Topically to Subjects With Moderate to Severe Plaque Psoria Psoriasis | Phase 2 | 2016-06-01 |
| Completed | Absorption and Systematic Pharmacokinetics of IDP-123 Lotion in Comparison With Tazorac Cream Acne | Phase 1 | 2016-06-01 |
| Completed | Safety and Efficacy of IDP-118 Lotion to Ultravate® in the Treatment of Plaque Psoriasis Psoriasis | Phase 2 | 2016-04-01 |
| Completed | Safety and Efficacy of Product 33525 (Luliconazole Cream 1%) in Pediatric Participants With Tinea Corporis Tinea Corporis | Phase 4 | 2016-02-08 |
| Completed | Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis Psoriasis | Phase 2 | 2016-02-01 |
| Completed | Long Term Safety Study of Plecanatide Irritable Bowel Syndrome | Phase 3 | 2016-01-01 |
| Completed | Maximal Use of Luliconazole Cream 1% in Pediatric Participants With Moderate to Severe Tinea Pedis or Tinea Cr Tinea Pedis, Tinea Cruris | Phase 4 | 2015-12-02 |
| Completed | Safety and Efficacy of IDP-122 in the Treatment of Participants With Plaque Psoriasis Plaque Psoriasis | Phase 3 | 2015-11-07 |
| Completed | Safety and Efficacy of IDP-122 in the Treatment of Participants With Plaque Psoriasis Plaque Psoriasis | Phase 3 | 2015-11-05 |
| Completed | Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris Acne | Phase 3 | 2015-11-04 |
| Completed | Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris Acne | Phase 3 | 2015-11-03 |
| Completed | Efficacy and Safety of IDP-120 Gel in the Treatment of Acne Vulgaris Acne Vulgaris | Phase 2 | 2015-11-01 |
| Completed | Safety and Efficacy of IDP-123 Lotion to Tazorac® Cream, in the Treatment of Acne Vulgaris Acne Vulgaris | Phase 2 | 2015-11-01 |
| Completed | Safety and Efficacy of IDP-118 in the Treatment of Plaque Psoriasis Plaque Psoriasis | Phase 3 | 2015-08-19 |
| Completed | Long-Term Safety of IDP-118 Lotion in the Treatment of Plaque Psoriasis Plaque Psoriasis | Phase 3 | 2015-08-11 |
| Completed | Safety and Efficacy of IDP-118 in the Treatment of Plaque Psoriasis Plaque Psoriasis | Phase 3 | 2015-08-11 |
| Completed | Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C) Irritable Bowel Syndrome Characterized by Constipation | Phase 3 | 2015-06-01 |
| Completed | Safety and Efficacy of Neuromultivit in Treatment of Vertebrogenic Radiculopathy Vertebrogenic Radiculopathy L5, S1 | Phase 3 | 2015-05-01 |
| Completed | Silicone Hydrogel Soft Contact Lens 7-Day Extended Wear Basis Myopia | N/A | 2015-04-30 |
| Completed | Topically Applied IDP-118 Lotion and HP Monad Lotion in Subjects With Moderate to Severe Plaque Psoriasis Psoriasis | Phase 1 | 2015-04-01 |
| Completed | Evaluation of the Safety, Systemic Pharmacokinetics, and Tolerability Eye Pain | Phase 1 | 2015-02-01 |
| Completed | The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C) Irritable Bowel Syndrome Characterized by Constipation | Phase 3 | 2014-12-01 |
| Terminated | One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease Crohn's Disease | Phase 3 | 2014-10-28 |
| Completed | A Bioequivalence Study Comparing a Single 1.5mL Dose of Brodalumab vs. Two Doses (1.0mL + 0.5mL) of Brodalumab Psoriasis | Phase 1 | 2014-09-01 |
| Terminated | One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease Crohn's Disease | Phase 3 | 2014-08-21 |
| Completed | 12-Week Study of Plecanatide for CIC (The National CIC3 Study) Chronic Idiopathic Constipation | Phase 3 | 2014-04-01 |
| Completed | Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis Psoriatic Arthritis | Phase 3 | 2014-03-01 |
| Terminated | Study of Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arth Psoriatic Arthritis | Phase 3 | 2014-03-01 |
| Completed | Absorption and Systematic Pharmacokinetics of IDP-121 Lotion in Subjects With Acne Vulgaris Acne | Phase 1 | 2014-02-01 |
| Completed | Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis Plaque Psoriasis | Phase 2 | 2014-02-01 |
| Completed | (C2013-0302) Safety and Efficacy of Escalating Doses of SAN-300 in Patients With Rheumatoid Arthritis Rheumatoid Arthritis | Phase 2 | 2013-12-01 |
| Completed | EYEFILL® C. -US Viscoelastic Clinical Investigation Cataract | N/A | 2013-12-01 |
| Completed | Dose-ranging Study to Assess Safety and Efficacy of SP-333 for the Treatment of Opioid-induced Constipation (O Constipation | Phase 2 | 2013-11-01 |
| Completed | 12-Week Study of Plecanatide for CIC (The CIC3 Study) Chronic Idiopathic Constipation | Phase 3 | 2013-11-01 |
| Completed | Brodalumab Drug-Drug Interaction (DDI) and Intensive Pharmacodynamic (PK) Study in Psoriasis Subjects Psoriasis | Phase 1 | 2013-09-01 |
| Completed | Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC) Chronic Idiopathic Constipation | Phase 3 | 2013-08-01 |
| Completed | Dose-ranging Study of Rifaximin Soluble Solid Dispersion (SSD) Tablets for the Prevention of Complications of Liver Cirrhosis | Phase 2 | 2013-06-01 |
| Terminated | Efficacy, Safety, And Pharmacokinetics Of Rifaximin In Subjects With Severe Hepatic Impairment And Hepatic Enc Hepatic Encephalopathy | Phase 4 | 2013-04-03 |
| Completed | The Safety/Efficacy of Rifaximin With/Without Lactulose in Participants With A History of Recurrent Hepatic En Hepatic Encephalopathy, Cirrhosis | Phase 4 | 2013-01-08 |
| Completed | The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C) Irritable Bowel Syndrome Characterized by Constipation | Phase 2 | 2012-11-01 |
| Completed | Single Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics (PK) of SP-333 Tablets i Exposure | Phase 1 | 2012-10-01 |
| Completed | Clinical Study to Test the Efficacy and Safety of ACYC to Treat Moderate to Severe Acne Acne | Phase 3 | 2012-10-01 |
| Terminated | Efficacy and Safety of Brodalumab Compared With Placebo and Ustekinumab in Moderate to Severe Plaque Psoriasis Plaque Psoriasis | Phase 3 | 2012-09-01 |
| Terminated | Efficacy, Safety, and Withdrawal and Retreatment With Brodalumab in Moderate to Severe Plaque Psoriasis Subjec Psoriasis | Phase 3 | 2012-08-01 |
| Terminated | P3 Study Brodalumab in Treatment of Moderate to Severe Plaque Psoriasis Moderate to Severe Plaque Psoriasis | Phase 3 | 2012-08-01 |
| Completed | Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (So Fecal Incontinence | — | 2012-05-31 |
| Completed | Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study Irritable Bowel Syndrome With Diarrhea | Phase 3 | 2012-02-01 |
| Completed | Randomized Placebo-Controlled Trial of Budesonide Multi-Matrix System (MMX®) 9 Milligrams (mg) in Participants Ulcerative Colitis | Phase 3 | 2012-01-27 |
| Terminated | AMG 827 in Subjects With Psoriatic Arthritis Psoriatic Arthritis | Phase 2 | 2011-10-01 |
| Completed | The Plecanatide Chronic Idiopathic Constipation (CIC) Study Chronic Idiopathic Constipation | Phase 2 / Phase 3 | 2011-10-01 |
| Completed | Safety and Efficacy of OsmoPrep® Tablets Versus HalfLytely® and Bisacodyl Tablet Bowel Prep Kit for Colon Clea Colon Cleansing | Phase 4 | 2011-09-16 |
| Completed | Safety and Tolerability of Crofelemer for HIV-Associated Diarrhea HIV Enteropathy, Diarrhea With HIV | Phase 3 | 2011-06-07 |
| Terminated | The Safety and Tolerability of Budesonide Foam in Participants With Active Ulcerative Proctitis or Proctosigmo Proctitis, Proctosigmoiditis | Phase 3 | 2011-05-31 |
| Completed | A Study of a New Drug Treatment for Acne Acne Vulgaris | Phase 2 | 2011-03-31 |
| Withdrawn | A Study of the Effectiveness and Safety of Tetrabenazine MR in Pediatric Subjects With Tourette's Syndrome Tourette's Syndrome | Phase 2 | 2011-03-01 |
| Completed | A Study That Evaluates the Decrease in Irritation When Using Additional Acne Treatment Products Acne Vulgaris | Phase 4 | 2010-12-01 |
| Completed | A Study of Oral Methylnaltrexone (MNTX) for the Treatment of Opioid-Induced Constipation (OIC) in Participants Opioid-Induced Constipation | Phase 3 | 2010-09-01 |
| Completed | Mesalamine Granules for Irritable Bowel Syndrome (IBS) With Diarrhea Irritable Bowel Syndrome With Diarrhea | Phase 2 | 2010-07-01 |
| Completed | Evaluate the Pharmacokinetics (PK) of Methylnaltrexone (MNTX) in Healthy Adult Subjects Healthy Adult Subjects | Phase 1 | 2010-07-01 |
| Completed | A Study Comparing the Safety and Tolerability of Two Doses of Fipamezole in Adult Patients With Parkinson's Di Parkinson's Disease | — | 2010-07-01 |
| Completed | A Study of Safety and Tolerability of Fipamezole in Adult Subjects With Parkinson's Disease Who Are Receiving Parkinson's Disease | — | 2010-06-01 |
| Terminated | Metyrosine (Demser®) for the Treatment of Psychotic Disorders in Patients With Velocardiofacial Syndrome Velo-cardio-facial Syndrome, Psychosis | Phase 2 | 2010-06-01 |
| Terminated | Study to Assess the Long-term Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Psoriasis Psoriasis | Phase 2 | 2010-04-01 |
| Completed | SP-304 Dose Ranging Study in Patients With Chronic Idiopathic Constipation Chronic Idiopathic Constipation | Phase 2 | 2010-03-01 |
| Completed | (CB-01-02/06) Oral Budesonide-Multi-Matrix System (MMX) 9mg Extended Release Tablets Colitis, Ulcerative | Phase 3 | 2010-02-01 |
| Completed | Study Evaluating Two Dose Levels of Targretin Capsules in Participants With Refractory Cutaneous T-Cell Lympho Refractory Cutaneous T-cell Lymphoma | Phase 4 | 2010-01-06 |
| Withdrawn | Study Evaluating MOA-728 Administered in Healthy Men Healthy | Phase 1 | 2010-01-01 |
| Completed | Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Psoriasis Psoriasis | Phase 2 | 2009-12-01 |
| Completed | Efficacy and Safety of Budesonide Foam for Participants With Active Mild to Moderate Ulcerative Proctitis or P Proctitis, Proctosigmoiditis | Phase 3 | 2009-11-20 |
| Completed | Efficacy and Safety of Budesonide Foam for Participants With Active Mild to Moderate Ulcerative Proctitis or P Proctitis, Proctosigmoiditis | Phase 3 | 2009-11-17 |
| Terminated | Study to Evaluate Efficacy and Safety in Male Subjects With Premature Ejaculation Premature Ejaculation | Phase 3 | 2009-10-01 |
| Terminated | Study to Evaluate Efficacy and Safety in Males Subjects With Premature Ejaculation Premature Ejaculation | Phase 3 | 2009-08-01 |
| Completed | Evaluation of Irritation That Potentially Could be Caused by Two Facial Gels Applied to Opposite Sides of the Acne Vulgaris | Phase 4 | 2009-07-01 |
| Completed | Study Evaluating the Efficacy and Safety of Subcutaneous Methylnaltrexone (MOA-728) for the Treatment of Opioi Constipation | Phase 3 | 2009-07-01 |
| Completed | Evaluation of Irritation by Two Facial Gels Applied to Opposite Sides of the Face Acne Vulgaris | Phase 4 | 2009-04-01 |
| Completed | Biopsy Study for Sculptra (Poly-L-Lactic Acid) Healthy Volunteers | N/A | 2009-03-01 |
| Withdrawn | Study Evaluating Safety & Efficacy of Subcutaneous Methylnaltrexone on Opioid-Induced Constipation in Cancer S Opioid-Induced Constipation | Phase 4 | 2009-03-01 |
| Completed | A Study of Acne Treatment in Children Ages 9 to 11 Acne Vulgaris | Phase 2 | 2009-02-01 |
| Completed | A Study of Different Use Regimens Using Two Acne Treatments Acne Vulgaris | Phase 4 | 2009-02-01 |
| Completed | Study Evaluating Long-Term Safety of MOA-728 in Participants With Opioid-Induced Constipation Constipation | Phase 3 | 2008-12-03 |
| Completed | (CB-01-02/04) Extension Study of Budesonide Multi-Matrix System (MMX) 6 mg in Maintenance Of Remission In Pati Ulcerative Colitis | Phase 3 | 2008-12-01 |
| Completed | Injectable POLY-L-Lactic Acid for Treatment of Hill and Valley Acne Scarring Acne Vulgaris | N/A | 2008-10-01 |
| Completed | Open-Label Study to Evaluate the Effect of Rifaximin on Midazolam in Normal Healthy Volunteers Pharmacokinetic | Phase 1 | 2008-09-01 |
| Completed | Rifaximin 3 Times/Day (TID) for Non-Constipation Irritable Bowel Syndrome (IBS) Non-Constipation Irritable Bowel Syndrome | Phase 3 | 2008-07-01 |
| Completed | Safety of Subcutaneous Methylnaltrexone for Opioid-Induced Constipation in Patients With Advanced Illness Opioid-Induced Constipation | Phase 4 | 2008-07-01 |
| Completed | Rifaximin 3 Times/Day (TID) for Non-Constipation Irritable Bowel Syndrome (IBS) Non-Constipation Irritable Bowel Syndrome | Phase 3 | 2008-07-01 |
| Completed | Study Evaluating Subcutaneous Methylnaltrexone For Treatment Of Opioid-Induced Constipation In Patients With A Opioid-Induced Constipation | Phase 4 | 2008-06-01 |
| Completed | (CB-01-02/02) Randomized Placebo Controlled Trial of Budesonide-multi-matrix System (MMX™) 6 mg and 9 mg in Pa Ulcerative Colitis | Phase 3 | 2008-06-01 |
| Completed | (CB-01-02/01) Randomized Placebo Controlled Trial of Budesonide-multi-matrix System (MMX™) 6 mg and 9 mg in Pa Ulcerative Colitis | Phase 3 | 2008-06-01 |
| Completed | PK Study of Encapsulated Mesalamine Granules in Healthy Volunteers Healthy | Phase 1 | 2008-02-01 |
| Completed | Evaluation of Irritation That Could be Caused by Two Facial Gels Applied to Opposite Sides of the Face. Acne Vulgaris | Phase 4 | 2008-01-01 |
| Completed | Study Evaluating MOA-728 Oral for the Treatment of OIBD in Subjects With Chronic Non-Malignant Pain Constipation | Phase 2 | 2008-01-01 |
| Completed | Single-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 827 Psoriasis | Phase 1 | 2007-12-01 |
| Completed | Study of Subcutaneous Methylnaltrexone (MNTX) in the Treatment of Opioid-Induced Constipation During Rehabilit Opioid-induced Constipation | Phase 2 | 2007-10-19 |
| Completed | A Study Evaluating Intravenous (IV) MOA-728 for the Treatment of Postoperative Ileus (POI) in Participants Aft Ileus | Phase 3 | 2007-10-17 |
| Completed | Safety/Efficacy Study of Retigabine vs. Placebo in Post-Herpetic Neuralgia (PHN) Postherpetic Neuralgia | Phase 2 | 2007-10-01 |
| Completed | Safety and Effectiveness of 3 Doses of Crofelemer Compared to Placebo in the Treatment of HIV Associated Diarr HIV Associated Diarrhea | Phase 3 | 2007-10-01 |
| Completed | Study Evaluating Oral MOA-728 For The Treatment Of OIBD In Subjects With Chronic Non-Malignant Pain Constipation | Phase 2 | 2007-10-01 |
| Completed | Study Evaluating Subcutaneous MOA-728 for the Treatment of Opioid-Induced Constipation (OIC) in Subjects With Constipation | Phase 3 | 2007-08-01 |
| Withdrawn | Study Evaluating Oral MOA-728 in Subjects on Methadone Therapy Methadone-maintenance Subjects | Phase 1 | 2007-07-01 |
| Completed | A Single-Center, Open-Label, Exploratory Study of the Volumizing Effect of SCULPTRA Measured by Three Dimensio Mid Facial Contour Deficiencies | — | 2007-06-01 |
| Completed | Study Evaluating the Safety and Tolerability of a New Intravenous Formulation of MOA-728 in Healthy Subjects Healthy | Phase 1 | 2007-04-01 |
| Completed | Safety and Tolerability Study of Rifaximin in Participants With a History of Hepatic Encephalopathy Hepatic Encephalopathy | Phase 3 | 2007-03-07 |
| Completed | Taribavirin Phase 2 Dose Finding Study for the Treatment of Hepatitis C Virus (HCV) Chronic Hepatitis C | Phase 2 | 2007-03-01 |
| Completed | Study Evaluating the Effects of MOA-728 on Cardiac Repolarization in Healthy Subjects Healthy | Phase 1 | 2007-03-01 |
| Completed | Study Evaluating MOA-728 in Subjects on Stable Methadone Maintenance Methadone-maintenance Subjects | Phase 1 | 2007-03-01 |
| Completed | Double-Blind, Double-Dummy, 2-Period Crossover of a 20-Minute Versus a 4-hour IV of MOA-728 in Stable Methadon Constipation | Phase 1 | 2007-03-01 |
| Completed | Canadian Aesthetic Experience With Sculptra Therapy Skin Aging | Phase 4 | 2007-01-01 |
| Completed | Effect of Cimetidine on the Single-Dose PK of IV- Administered MNTX Healthy Adult Subjects | Phase 1 | 2007-01-01 |
| Completed | Study Evaluating IV Methylnaltrexone for the Treatment of Post Operative Ileus Post Operative Bowel Dysfunction | Phase 3 | 2006-12-01 |
| Completed | Study of Intravenous (IV) Methylnaltrexone Bromide (MNTX) in the Treatment of Post-Operative Ileus (POI) Post-Operative Ileus (POI) | Phase 3 | 2006-10-31 |
| Completed | Diarrhea Predominant Irritable Bowel Syndrome in Females Irritable Bowel Syndrome | Phase 2 | 2006-10-01 |
| Completed | Study of Pharmacokinetics, Safety and Tolerability of Intravenous Methylnaltrexone Bromide Healthy Adults | Phase 1 | 2006-10-01 |
| Completed | Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study Inflammatory Bowel Disease, Ulcerative Colitis | Phase 3 | 2006-10-01 |
| Completed | Comparisons Of The Bioavailability And Pharmacodynamics Of Various Formulations Of MOA-728 In Subjects On Meth Metahdone-maintenance Subjects | Phase 1 | 2006-10-01 |
| Completed | A Randomized, Blinded, Multicenter Study to Evaluate NASHA/Dx for the Treatment of Fecal Incontinence Fecal Incontinence | N/A | 2006-09-07 |
| Completed | Study Evaluating Oral MOA-728 for the Treatment of Opioid-Induced Bowel Dysfunction (OIBD) in Subjects With Ch Constipation | Phase 2 | 2006-08-01 |
| Completed | Bioequivalence Study in Healthy Volunteers Healthy | Phase 1 | 2006-08-01 |
| Completed | Dose Ranging Study in Healthy Methadone Maintenance Subjects Adult | Phase 1 | 2006-06-01 |
| Completed | Balsalazide Disodium vs. Mesalamine in Mildly to Moderately Active Ulcerative Colitis Inflammatory Bowel Disease, Ulcerative Colitis | Phase 3 | 2006-05-01 |
| Completed | Effects of MNTX on CYP450 2D6 in Metabolizers of Dextromethorphan Healthy Adults | Phase 1 | 2006-03-01 |
| Completed | Study Evaluating the Safety of MOA-728 Administered Orally to Healthy Subjects Postoperative Complications, Constipation | Phase 1 | 2006-03-01 |
| Completed | Long-Term Safety and Tolerability of Mesalamine Pellets in Participants With Ulcerative Colitis in Remission Ulcerative Colitis | Phase 3 | 2005-12-22 |
| Completed | A 6-month Efficacy, Safety, and Tolerability Study of Rifaximin In Preventing Hepatic Encephalopathy Hepatic Encephalopathy | Phase 3 | 2005-12-19 |
| Completed | Prevention of Travelers' Diarrhea in Subjects Traveling Outside the U.S. Diarrhea | Phase 3 | 2005-12-01 |
| Completed | New Tablet Formulation and Dosing Regimen of Balsalazide Disodium in Mildly to Moderately Active Ulcerative Co Ulcerative Colitis | Phase 3 | 2005-12-01 |
| Completed | Study to Assess the Efficacy and Safety of Rifaximin Administered BID in the Treatment of Patients With Diarrh Irritable Bowel Syndrome | Phase 2 | 2005-12-01 |
| Completed | A Trial to Compare Xifaxan to Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD) Clostridium Infections, Diarrhea | Phase 3 | 2005-12-01 |
| Terminated | Viral Kinetic Study With Viramidine in Therapy-Naive Patients With Chronic Hepatitis C Hepatitis C, Chronic | Phase 2 | 2005-11-01 |
| Completed | Facial Lipoatrophy Correction Experience With SCULPTRA ("FACES" Study) Facial Lipoatrophy | — | 2005-10-01 |
| Active Not Recruiting | 10 Year Registry of Children (Ages 2-17 Years) With Eczema That Have Used Pimecrolimus Atopic Dermatitis | — | 2005-06-27 |
| Completed | Rifaximin for Prevention of Travellers' Diarrhea Diarrhea | Phase 3 | 2005-06-01 |
| Terminated | Open-label Treatment Extension Study for Patients Who Complete Study RNA200103-201 Hepatitis B, Chronic | Phase 2 | 2005-06-01 |
| Completed | Study of the Pharmacokinetics of Intravenous Administered 14C-MNTX Healthy Male Volunteers | Phase 1 | 2005-06-01 |
| Completed | Daily-Dose Consensus Interferon and Ribavirin: Efficacy of Combined Therapy Chronic Hepatitis C | Phase 3 | 2005-02-01 |
| Completed | A Study of Crofelemer to Treat Diarrhea Irritable Bowel Syndrome Irritable Bowel Syndrome, Colonic Diseases, Diarrhea | Phase 2 | 2004-12-01 |
| Completed | Mesalamine Pellet Formulation to Maintain Remission of Mild to Moderate Ulcerative Colitis Ulcerative Colitis | Phase 3 | 2004-12-01 |
| Completed | Mesalamine Pellet to Maintain Remission of Mild to Moderate Ulcerative Colitis Ulcerative Colitis | Phase 3 | 2004-12-01 |
| Completed | Effect of Methylnaltrexone (MNTX) on Electrocardiogram (ECG) Parameters and Cardiac Repolarization Healthy Volunteers | Phase 1 | 2004-11-01 |
| Completed | DL6049 Versus Cosmoplast in the Treatment of Nasolabial Fold Wrinkles, Long Term Follow-up Nasolabial Fold Wrinkles | Phase 3 | 2004-08-01 |
| Completed | Dose-Ranging Study of Pradefovir in Patients With Compensated Hepatitis B Hepatitis B, Chronic | Phase 2 | 2004-06-01 |
| Completed | Study of Viramidine to Ribavirin in Patients With Chronic Hepatitis C Who Are Treatment Naive Chronic Hepatitis C | Phase 3 | 2004-06-01 |
| Completed | DL6049 vs CosmoPlast in the Treatment of Nasolabial Fold Wrinkles Nasolabial Fold Wrinkles | Phase 3 | 2004-06-01 |
| Completed | Daily-Dose Consensus Interferon and Ribavirin: Efficacy of Combined Therapy Chronic Hepatitis C | Phase 3 | 2004-06-01 |
| Completed | Pharmacokinetics, Safety, and Tolerability of Methylnaltrexone in Volunteers With Impaired Hepatic Function Liver Dysfunction | Phase 1 | 2004-03-01 |
| Completed | Pharmacokinetics, Safety, and Tolerability of Methylnaltrexone (MNTX) in Subjects With Impaired Renal Function Renal Impairment | Phase 1 | 2004-03-01 |
| Completed | Open-Label Treatment Extension of Protocol MNTX 302 Terminal Illness | Phase 3 | 2004-03-01 |
| Completed | Study of Methylnaltrexone (MNTX) for the Relief of Constipation Advance Illness Patients With OIC | Phase 3 | 2004-02-01 |
| Completed | Pharmacokinetics and Bioavailability Comparison of Two Different Formulations of MNTX Tablets Normal Volunteers | Phase 1 | 2004-02-01 |
| Completed | Study of Viramidine to Ribavirin in Patients With Chronic Hepatitis C Who Are Treatment-Naive Chronic Hepatitis C | Phase 3 | 2003-12-01 |
| Completed | Tolerance and Pharmacokinetics Study of MNTX Tablets Normal Healthy Volunteers | Phase 1 | 2003-10-01 |
| Completed | Intravenous (IV) Methylnaltrexone (MNTX) in the Prevention of Post-Operative Ileus Postoperative Ileus | Phase 2 | 2003-07-01 |
| Completed | Open-Label Treatment Extension of Protocol MNTX 301 Terminal Illness | Phase 3 | 2003-02-01 |
| Completed | A a Single Dose Efficacy Study in Inducing Laxation in Advance Illness Patients Advanced Illness Patients With Opioid Induced Constipation | Phase 3 | 2003-02-01 |
| Completed | Compassionate Use Study of Methylnaltrexone Opioid-induced Constipation | N/A | 2003-01-24 |
| Completed | Naloxone and Intravenous Methylnaltrexone Effects on Bladder Function Healthy Males | Phase 1 | 2002-10-01 |
| Completed | A Study Comparing the Effectiveness and Safety of Extended Release Tramadol HCl at 100 mg, 200 mg and 300 mg D Chronic Pain | Phase 3 | 2002-09-01 |
| Completed | Pharmacokinetics and Bioavailability of Single Subcutaneous Doses of Methylnaltrexone Versus Intravenous Dose Healthy Subjects | Phase 1 | 2002-06-01 |
| Completed | Safety & Efficacy of Omeprazole Sodium Bicarbonate for the Prevention of Upper GI Bleeding in the Critically I Upper Gastrointestinal Bleeding | Phase 3 | 2002-05-01 |
| Completed | Methylnaltrexone in Patients With Opioid-Induced Bowel Dysfunction Bowel Dysfunction | Phase 2 | 2002-04-01 |
| Completed | Safety and Gastrointestinal Effects of Intravenous Methylnaltrexone Healthy Volunteers | Phase 2 | 2002-04-01 |
| Completed | A Study Comparing the Effectiveness and Safety of Varying Dose Strengths (100, 200, 300 and 400 mg) of Extende Chronic Pain | Phase 3 | 2002-01-01 |
| Completed | A Study Comparing the Effectiveness and Safety of Extended-release Tramadol Versus Placebo in the Treatment of Chronic Pain | Phase 3 | 2000-11-01 |
| Completed | A Study Comparing the Effectiveness and Safety of Extended Release Tramadol Versus Placebo for the Treatment o Chronic Pain | Phase 3 | 2000-11-01 |
| Completed | A One-year, Open-label Study to Assess the Safety and Effectiveness of Extended Release Tramadol HCl in the Tr Chronic Pain | Phase 3 | 2000-10-01 |
| No Longer Available | Compassionate Use Study of Pergolide in Patients With Parkinson's Disease Parkinson Disease | — | — |